SCHEMBL30770975

SCHEMBL30770975

Nc1cc(Br)c2c(c1)OC(F)(F)O2

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25166563 1.00 GAA (0.38) GAAMAPT
SCHEMBL12879243 0.77 ALDH1A1 (0.30)
SCHEMBL13395581 0.76 GAA (0.32) GAAMAPT
SCHEMBL20355024 0.72 KDM4E (0.40) GAAMAPT
SCHEMBL30177616 0.69 MEN1 (0.38) MAPT
SCHEMBL3342338 0.69 MEN1 (0.38) MAPT
SCHEMBL1752066 0.69 AHR (0.48)
SCHEMBL16798562 0.69 ADORA2A (0.38)
SCHEMBL16798646 0.69 ADORA2A (0.30)
SCHEMBL25082874 0.69 ADORA2A (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4561563-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF Ensem Therapeutics, Inc. (US) 2025-06-04 EP disclosed
WO-2024026129-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed